
EQS-News: Cantourage Group SE
/ Key word(s): Development of Sales/Rating
15.05.2025 / 07:07 CET/CEST Not for direct or indirect publication or distribution within or in the United States of America, Australia, Canada or Japan or any other jurisdiction where such publication or distribution would be unlawful. Please note the important information at the end of this announcement. PRESS RELEASE Cantourage achieves another record revenue: EUR 11.1 million in April 2025 Berlin, 15 May 2025 – Cantourage Group SE (hereinafter ‘Cantourage’, ISIN: DE000A3DSV01, www.cantourage.com), Europe's leading publicly traded medical cannabis company, continues its dynamic growth trajectory. In April 2025, the company achieved the highest monthly revenue in its history at EUR 11.1 million, surpassing its previous record from March (EUR 10.7 million) in the very next month. High-level growth stabilises – demand remains strong About Cantourage Cantourage ensures the highest pharmaceutical quality standards along the value chain and offers products in all relevant market segments: dried flowers, extracts, dronabinol and cannabidiol. The company has been listed on the Frankfurt Stock Exchange since 11 November 2022 and is traded under the ticker symbol ‘HIGH’. Press contacts This announcement does not constitute a public offer or an advertisement for a public offer to sell securities, in particular not within the meaning of Regulation (EU) 2017/1129 (Prospectus Regulation). 15.05.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Cantourage Group SE |
| Feurigstraße 54 | |
| 10827 Berlin | |
| Germany | |
| E-mail: | [email protected] |
| Internet: | https://www.cantourage.com/ |
| ISIN: | DE000A3DSV01 |
| WKN: | A3DSV0 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2137800 |
| End of News | EQS News Service |
2137800 15.05.2025 CET/CEST
